Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 1997

View Archived Issues

Company Profile: NitroMed

Airways-selective inhaled steroid for the treatment of asthma

Antiproliferative effects of PCA-4230 in vascular smooth muscle cells

Endothelin receptor blockade for airways inflammation

ABT-080 effective in animal model of lung eosinophilia

In vitro characterization of novel CysLTD1 receptor antagonist

Selectin inhibitor effective in animal model of early- and late-phase airways inflammation

Preclinical studies demonstrate antiinflammatory effects of selective PDE IV inhibitor

Tiotropium safe and effective in COPD

Anti-CD4 MAb effective in chronic, severe asthma

Briana Bio-Tech signs licensing agreement for chronic MS treatment

Cell Pathways commences phase III trial for prevention of precancerous colon polyps

LAS-31025 demonstrates good safety and efficacy in mild to moderate asthma

CoCensys enters licensing agreement with Wyeth-Ayerst for anxiety treatment

Insights on asthma research approaches

Novartis prepares gene therapy clinical trial for the treatment of brain tumors

Steroid-dependent asthma improved by treatment with FLAP inhibitor

Clinical response to PAF antagonist associated with adhesion molecule suppression

FDA clears Glaxo Wellcome's aid to smoking cessation

SR-27417A protects against inhaled PAF-induced effects in asthmatics

Abelcet earns regulatory approval in Switzerland

Campto now available in seven additional countries

NIH announces prospective grant of licenses for IL-12 antibodies

NIH announces prospective grant of exclusive license for IL-13 receptor-specific chimeric antibodies

Salix reports promising clinical results for ulcerative colitis treatment

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...